Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer Has an Activist. Pharma Giant Is Latest Target of Starboard.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have expressed interest in helping, The Wall Street Journal reported Sunday, citing people familiar with the matter.
Activist investor Starboard Value takes $1 billion stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.
Activist investor Starboard has informed Pfizer it has taken a stake
Starboard Value has taken a stake in Pfizer, people familiar with the matter said.The drug giant's stock price has dropped significantly since its COVID-19 vaccine rollout.Starboard's stake in Pfizer is reportedly worth about $1 billion.
Activist investor Starboard builds $1bn position in drugmaker Pfizer
Activist investor Starboard Value has built a $1bn position in Pfizer, according to two people familiar with the matter, as the drugmaker behind the top-selling Covid-19 jab struggles to reverse a fall in its share price to below pre-pandemic levels.
Activist Starboard Value Takes $1 Billion Stake in Pfizer
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of the struggling pharmaceuticals giant, according to a person familiar with the matter.
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
Starboard's stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand for its Covid-19 medicines recedes.
Pfizer faces pressure as activist investor Starboard Value takes $1 billion stake
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance. Starboard has reached out to former execs for assistance, while Pfizer faces challenges with falling COVID-19 sales and competition for its drugs.
2d
on MSN
Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August
An examination of layoffs in pharmaceutical and biotechnology companies in Q3 shows that as the summer progressed, the number ...
5h
The US wants to cut its reliance on Chinese pharma. These stocks could benefit.
On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...
4h
AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history
Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American ...
3d
Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH
VanEck Pharmaceutical ETF has shown strong performance but faces near-term downside risks, prompting a rating downgrade to ...
Richmond BizSense
5h
Richmond-based pharma company Kaleo laying off dozens of employees
The company described the move as a “mass layoff of its sales representatives and related employees across the country,” ...
1h
Mankind Pharma, Bajaj Housing, Ola Electric, 40 others to exit IPO lock-in
Here is the complete list of stocks exiting their IPO lock-in period between October 8, 2024, and December 31, 2024 ...
17h
Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma
Kirk Spano and Bhavneesh Sharma talk biotech, pharma, and why complete response letters are a good contrarian buying ...
3d
on MSN
Pharma company funding for patient advocacy groups needs to be transparent, says researcher
Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the ...
1h
Natco Pharma soars after Mylan settles Ozempic patent dispute
Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic.
MM&M
2d
Real Chemistry strikes partnership with Corval, aiming to tackle biggest challenges in pharma commercialization
The partnership will combine Real Chemistry’s consultative and strategic expertise with Corval’s commercialization planning ...
India Infoline
2h
Natco Pharma settles US patent case over generic Ozempic
According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.
4h
Here's why Natco Pharma share price gained over 4% on October 7; details
Natco Pharma share rose after the company announced that Mylan Pharmaceuticals Inc & Novo Nordisk have reached a settlement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Pfizer
United States
New Jersey
Piramal
Indian rupee
Feedback